Sonic Gp LLC Fennec Pharmaceuticals Inc. Transaction History
Sonic Gp LLC
- $48.4 Billion
- Q2 2024
A detailed history of Sonic Gp LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Sonic Gp LLC holds 2,407,357 shares of FENC stock, worth $10.8 Million. This represents 30.37% of its overall portfolio holdings.
Number of Shares
2,407,357
Previous 2,407,357
-0.0%
Holding current value
$10.8 Million
Previous $26.8 Billion
45.05%
% of portfolio
30.37%
Previous 35.34%
Shares
1 transactions
Others Institutions Holding FENC
# of Institutions
66Shares Held
14.3MCall Options Held
10KPut Options Held
83.8K-
Southpoint Capital Advisors LP New York, NY4.08MShares$18.2 Million0.73% of portfolio
-
Dg Capital Management, LLC New York, NY1.63MShares$7.31 Million3.85% of portfolio
-
Solas Capital Management, LLC Darien, CT1.34MShares$5.99 Million4.92% of portfolio
-
Black Rock Inc. New York, NY1.19MShares$5.31 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.03MShares$4.59 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $117M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...